"Icon Cancer Centre South Brisbane offers a full range of cancer treatments and blood disorder treatments. The centre is located in the Mater precinct with direct access to Mater Private Hospital. Treatment options include chemotherapy, immunotherapy, targeted therapies, apheresis and treatment for blood disorders. Icon has access to dedicated cancer care coordinators, scalp cooling systems, clinical trials, pharmacy and allied health services. There is no wait list, ensuring patients receive immediate access to consultation and treatment. The centre has a team of caring medical oncologists, haematologists, oncology nurses and administrative staff. Parking is available at Mater Private Medical Centre."

During the past decade, Icon Cancer Care conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Icon Cancer Care" #1 sponsor was "Atridia Pty Ltd." with 2 trials, followed by "BeiGene" with 2 trials sponsored, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Constellation Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Icon Cancer Care" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "Myriad Genetic Laboratories, Inc." with 1 trials as a collaborator and "Tigermed Consulting Co., Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Icon Cancer Care" are "Advanced Solid Tumor" (2 trials), "Advanced Cancer" (1 trials), "Advanced Carcinoma" (1 trials), "Advanced Malignancies" (1 trials) and "Advanced Malignant Tumors" (1 trials). Many other conditions were trialed in "Icon Cancer Care" in a lesser frequency.

Most popular intervention types in "Icon Cancer Care" are "Drug" (8 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "AMT-151" (1 trials), "Capecitabine 1000 mg/m² PO BID" (1 trials), "NAH therapy" (1 trials), "Pamiparib" (1 trials) and "Pamiparib 20, 40, 60 mg PO Twice Daily (BID)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Icon Cancer Care" are 7 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Icon Cancer Care". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Icon Cancer Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Icon Cancer Care, 4 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Icon Cancer Care has several departments that took part in Clinical trials: "Icon Cancer Care Southport" - 15 trials, "Icon Cancer Care Chermside" - 13 trials, "Icon Cancer Centre Hobart" - 10 trials, "Ashford Cancer Centre Research" - 75 trials, "Icon Cancer Care South Brisbane" - 47 trials, "Toowoomba Cancer Research Centre" - 3 trials, "Icon Cancer Care Wesley" - 29 trials, "ICON Cancer Centre, Gold Coast University Hospital" - 2 trials